SAN DIEGO, April 30, 2019 /PRNewswire/ -- Vividion Therapeutics, a biotechnology company with a revolutionary platform to discover small molecule therapeutics against biologically compelling but previously intractable targets, today announced the completion of an oversubscribed $82...
from PR Newswire: https://prn.to/2GUaPQU
No comments:
Post a Comment